Inside the Texas Heart Studio

In this thought-provoking conversation, Dr. Mehdi Razavi joins Dr. Joe Rogers at the Texas Heart Institute to discuss groundbreaking innovations in cardiac electrophysiology. Dr. Razavi introduces the concept of imperceptible defibrillation—a method to reset the heart’s rhythm without painful shocks—using synchronized pacing and conductive hydrogels. These hydrogels act as “electrical highways,” enabling precise control of heart rhythms and potentially transforming treatment for atrial and ventricular fibrillation. The discussion also explores the role of AI, machine learning, and digital twins in personalizing care and advancing cardiac therapies. This visionary approach could redefine how we treat arrhythmias and improve patient quality of life.

Visit Our Website: texasheart.org

In this inspiring conversation hosted by Dr. Joe Rogers of the Texas Heart Institute, Dr. Mehdi Razavi shares how clinical experience drives innovation in medicine. Drawing from real patient interactions, Dr. Razavi emphasizes the importance of identifying unmet needs and collaborating across disciplines to develop impactful technologies. He discusses the value of humility, listening to experts, and adapting ideas based on feedback—highlighting a pivotal shift from electromagnetic to magnetoelectric technology in cardiac care. For aspiring innovators, his message is clear: trust your ideas, seek collaboration, and never underestimate the power of persistence.

Visit Our Website: texasheart.org

In this episode of Inside the Studio, Dr. Joseph Rogers from the Texas Heart Institute talks with Dr. Diana Milewicz about the role of genetics in aortic and other vascular diseases. They discuss how many people with conditions like aortic aneurysms may go undiagnosed due to missed family history or subtle symptoms.

Dr. Milewicz emphasizes the importance of asking patients about their family medical history, especially sudden deaths or dissections, which can signal inherited risks. She also highlights new technologies like facial recognition and artificial intelligence that could help doctors identify genetic conditions more accurately and earlier.

The conversation touches on ethical concerns around privacy and genetic testing, the need for better treatments to prevent deadly dissections, and the future of personalized medicine using genome sequencing and smart tools to guide care.

Overall, the episode sheds light on how genetics is transforming heart and vascular care, and why early detection and innovation are key to saving lives.

Visit Our Website: texasheart.org

In this engaging discussion, Dr. Joe Rogers of the Texas Heart Institute sits down with Dr. Paul Klotman, outgoing President and CEO of Baylor College of Medicine, to explore the future of healthcare, medical education, and research. Reflecting on his career and the evolving landscape of academic medicine, Dr. Klotman shares insights on challenges facing medical schools, the importance of combating medical misinformation, and the promise of AI in healthcare. He also highlights innovations in medical education, including simulation-based learning and early clinical exposure. This thoughtful conversation offers a forward-looking perspective on how institutions can adapt to better serve both students and society.

Visit Our Website: texasheart.org

On Episode 48 of Inside the Studio, Dr. Sri Kartik Valluri sits down with Dr. Jeffrey L. Carson following Grand Rounds at The Texas Heart Institute to discuss new insights on transfusion practices in cardiovascular care.

Highlights:

• Review of the MINT trial and other key studies
• Shift from restrictive to more liberal transfusion strategies
• Importance of individualized treatment for patients with AMI and post-cardiotomy status
• The role of clinical judgment in applying evolving evidence
• Future research directions in patients with cardiovascular disease

🔗 Register for upcoming symposia: https://www.texasheart.org/our-symposia/

Visit Our Website: texasheart.org

On episode 46 of Inside the Studio, Dr. Joseph G. Rogers sits down with Dr. Mathew S. Maurer to explore cardiac amyloidosis, highlighting the importance of patient evaluation and diagnostic algorithms. They discuss the necessity of thorough diagnostic processes, including biopsies, and the significance of genotyping. 

Further in the discussion, they cover:

• The practical approach to diagnosing cardiac amyloidosis from initial patient presentation.
• The critical steps in differentiating AL and TTR amyloidosis.
• The role of genotyping in determining prognosis and guiding treatment decisions.
• The importance of endomyocardial biopsies, particularly when monoclonal proteins are identified.
• Insights into the natural history of wild-type TTR amyloidosis and the factors influencing its development in older adults.
• The latest therapeutic strategies and the necessity of multidisciplinary collaboration, particularly with hematology-oncology.

Register for our upcoming symposia: https://www.texasheart.org/our-symposia

Visit Our Website: texasheart.org

On episode 44 of Inside the Studio, Dr. Ajith Nair sits down with Dr. Ajay Kirtane, Professor of Medicine at Columbia Presbyterian and Director of Interventional Services, to discuss his approaches to stable coronary artery disease. 

The conversation covers:

• Balancing evidence-based medicine with patient-centered care
• Evaluating symptoms and prognosis to guide treatment
• Optimizing guideline-directed medical therapy
• Identifying high-risk patients for further testing or intervention
• Strategies for diagnosing different types of coronary artery disease

Watch this episode on Texas Heart TV:  https://tv.texasheart.org/inside-the-studio/videos/approaches-to-stable-coronary-artery-disease-w-dr-ajay-kirtane

Register for upcoming symposia: https://www.texasheart.org/our-symposia/ 

Visit Our Website: texasheart.org

In this episode of Inside the Studio, Dr. Emerson C. Perin speaks with Dr. Patrick T. O'Gara, a distinguished professor of cardiology from Harvard Medical School. They explore the evolving field of cardiology, focusing on the critical importance of genetics and artificial intelligence in enhancing patient care. 

Key highlights include:

• The challenges faced by cardiologists in the 21st century
• The integration of genetic testing into clinical practice
• The role of artificial intelligence in predicting patient outcomes
• Emerging trends in valvular heart disease and transcatheter therapies
• The future of clinical research and evidence-based medicine in cardiology

Watch this episode on Texas Heart TV: https://tv.texasheart.org/inside-the-studio/videos/cardiology-crossroads-genetics-ai-and-the-future-of-heart-care

Register for upcoming symposia: https://www.texasheart.org/our-symposia/ 

Visit Our Website: texasheart.org

On episode 43 of Inside the Studio, Dr. Joseph G. Rogers, Director of The Texas Heart Institute at Baylor College of Medicine, sits down with Grand Rounds guest Dr. Hartzell Vernon Schaff, the Stuart W. Harrington Professor of Surgery at Mayo Clinic, and the recipient of the THI's highest honor, the 2025 Ray C. Fish Award for Scientific Achievement. 

In this conversation, Dr. Schaff shares his insights on mitral regurgitation and its clinical implications:

• Valvular Heart Disease: Dr. Rogers and Dr. Schaff discuss key considerations in assessing and managing patients with valvular heart disease, especially those with mitral regurgitation.
• Functional Mitral Regurgitation: Dr. Schaff dives into the challenges of managing functional mitral regurgitation as patients' ejection fraction drops, discussing the evolving approach to treatment.
• Surgical vs. Percutaneous Approaches: The duo explores the different approaches to mitral regurgitation, including when to consider surgery or percutaneous interventions, such as mitral valve repair, replacement, and the mitral clip.
• Patient-Centric Decision Making: Emphasizing a patient-centered approach, they discuss how to determine the right course of action for patients with heart failure and significant mitral regurgitation.
• Long-Term Outcomes: Dr. Schaff highlights that while interventions can improve symptoms, they may not necessarily impact long-term survival in certain cases.

Register for upcoming symposia: https://www.texasheart.org/education/our-symposia/

Visit Our Website: texasheart.org

On episode 42 of Inside the Studio, Dr. Joseph Rogers, THI President and CEO, sits down with Grand Rounds guest Dr. Allan L. Klein from Cleveland Clinic to discuss pericarditis, a disease often overlooked. Dr. Klein shares his expertise on diagnosing subtle presentations, the importance of clinical examination, and the latest advancements in treatment, including biologics and the role of exercise.

Register for upcoming live talks at https://www.texasheart.org/grandrounds

Watch the sit-down interview: https://tv.texasheart.org/inside-the-studio/videos/exploring-pericarditis-diagnosis-challenges-and-clinical-insights

Visit Our Website: texasheart.org